Long-term hepatitis B surface antigen response after finite treatment with siRNAs ARC-520 or JNJ-3989
Latest Information Update: 20 Aug 2024
At a glance
- Drugs ARC 520 (Primary) ; JNJ 73763989 (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
Most Recent Events
- 20 Aug 2024 New trial record